Article
Preclinical Evaluation of Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb Ischemia
2021-08-04
Abstract excerpt
<title>Abstract</title> <p><bold>Introduction: </bold>Critical limb ischemia (CLI) considered as the most severe form of peripheral artery disease (PAD). Current therapy for CLI are surgical reconstruction and endovascular therapy or limb amputation (for patients with no treatment options). Neovasculogenesis induced by stem cells including mesenchymal stem cells (MSCs) therapy is a promising approach to treat CLI...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 65529fa3-45fc-5c65-87d4-c4c053d3a2fa
- DOI
- 10.21203/rs.3.rs-653222/v2
